Health investigates the death of a 35-year-old military man due to blood clots 17 days after being vaccinated with AstraZeneca

Health is investigating the death of corporal FPB, 35, assigned to the Infantry Regiment América 66 de Cazadores de Montaña, based in the Aizoáin barracks, Navarra, after suffering a “cerebral sinus thrombosis with thrombocytopenia and cerebral hemorrhage ”, 17 days after receiving the AstraZeneca vaccine. The military man died this morning at the University Clinic of Navarra. The family decided to donate their organs, the Army reported this Saturday.

More information

The case has already been brought to the attention of the health authorities to evaluate its relationship with the vaccine. The Pharmacovigilance Center of the Navarra Department of Health received a notification of an “adverse event with a fatal outcome” from a person who had been vaccinated with Vaxzevria (AstraZeneca’s covid vaccine) on April 7. The Government of Navarra immediately communicated the fact to the Spanish Agency for Medicines and Health Products (AEMPS), as well as the rest of the regional pharmacovigilance centers.

The case, according to current protocols, will be studied by the AEMPS in a network investigation. This body permanently evaluates the suspected adverse reactions reported in Spain with all authorized drugs, including vaccines and their different types.

The corporal, married and expecting a child, was vaccinated with AstraZeneca on the afternoon of April 7 in his own unit. The Spanish Troop and Sailor Association (ATME) explained that in the following days he suffered “severe headaches and acute discomfort”, forcing him to go to the barracks first aid kit and then to the emergency room of a health center from Pamplona. On the night of this last Wednesday, April 21, the corporal suffered a faint while he was at his home, according to the Army, to which America 66 belongs.

Vaccination in the Army has taken place outside the Navarre public health system, as it is the responsibility of the State and not of the provincial community. His unit was included in the vaccination plan, which established the Oxford serum for children under 60 years of age belonging to second-line health fields (pharmacists, health students in training, etc.), personnel of the security and emergency forces, and teachers, among others.

However, the same day he was vaccinated, the Interterritorial Health Council decided to suspend vaccination with AstraZeneca for those under 60 years of age, based on a report from the European Medicines Agency (EMA) that recognized a “ possible link ”between this vaccine and blood clots with low platelet levels. Until then, 222 cases of thrombi had been counted among 35 million doses administered in the European Union. These episodes, however, are very exceptional, and the European agency itself defends that the benefits of applying the vaccine far outweigh the risks.

Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more

Leave a Reply